Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Stephen Glenn Slade , MD

Ophthalmology • Houston, TX

Active NPI 1386693752 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

3900 Essex Ln, Suite 101
Houston, TX 770275133

Call 7136265544 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

3900 Essex Ln
Suite 101

Houston, TX 770275133

Telephone 7136265544
Fax 7136267744
Organization at the Same NPPES Address or Phone
Snoring Center Of Houston Pa Facility NPI 1598058018

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Stephen Glenn Slade Md Pa. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

University Of Texas Medical School At Houston

Graduation Year

1978

Medicare patients

327 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $181,926 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $138,575 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

2,876 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$458,944 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $16,856.86 across 44 records.

By nature of payment (3 largest of 5)

  • Consulting Fee: $13,427.75 across 7 records.
  • Food and Beverage: $2,771.87 across 32 records.
  • Travel and Lodging: $443.90 across 2 records.

Reporting-company totals (3 largest of 11)

  • LENSAR, Inc.: $13,123.94 across 11 records.
  • RxSight Inc: $1,449.03 across 8 records.
  • Alcon Research LLC: $1,183.85 across 2 records.

Research and ownership records are not included in these totals; they are in the table below.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

48 years (graduated 1978)

CMS Doctors and Clinicians data list 1978 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Slade has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Slade as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Houston and Texas

Billing and prescribing volume is not a quality rating.

Medicare Part B services

Fewer Medicare Part B services than 70% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: 1,290. Middle half: 512 to 2,999.

Fewer Medicare Part B services than 75% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.

Medicare-allowed amount

Close to the middle for clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: $164,118. Middle half: $46,762 to $332,685.

Close to the middle for clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.

Paid by Medicare

Close to the middle for clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: $121,752. Middle half: $34,732 to $241,863.

Close to the middle for clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.

Medicare Part D prescriptions

More Part D prescriptions than 75% of clinicians listed under Ophthalmology in Houston, TX (2024, 175 clinicians with data). Median for this group: 655. Middle half: 221 to 2,095.

More Part D prescriptions than 70% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.

Part D drug cost

A higher Part D drug cost than 80% of clinicians listed under Ophthalmology in Houston, TX (2024, 175 clinicians with data). Median for this group: $43,974. Middle half: $8,242 to $251,495.

A higher Part D drug cost than 85% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.

262 active clinicians are listed under Ophthalmology with a practice address in Houston, TX (1,517 in Texas).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Houston

1.9% of these 262 clinicians have the CMS telehealth indicator.

64.1% of these 262 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 45 records totaling $41,194.36.

Manufacturer Payment Nature Product Type Amount ($)
LENSAR, INC.
Ownership Interest
— Ownership $24,337.50
LENSAR, Inc.
Consulting Fee
Cash or cash equivalent
LENSAR LASER SYSTEM General $5,000.00
LENSAR, Inc.
Consulting Fee
Cash or cash equivalent
LENSAR LASER SYSTEM General $3,712.50
LENSAR, Inc.
Consulting Fee
Cash or cash equivalent
LENSAR LASER SYSTEM General $1,865.25
Alcon Research LLC
Consulting Fee
Cash or cash equivalent
Wavelight Refractive Suite General $1,000.00
LENSAR, Inc.
Consulting Fee
Cash or cash equivalent
LENSAR LASER SYSTEM General $825.00
RxSight Inc
Consulting Fee
Cash or cash equivalent
RXSIGHT CONTACT LENS General $750.00
LENSAR, Inc.
Food and Beverage
Cash or cash equivalent
LENSAR LASER SYSTEM General $541.18
LENSAR, Inc.
Consulting Fee
Cash or cash equivalent
LENSAR LASER SYSTEM General $275.00
LENSAR, Inc.
Food and Beverage
Cash or cash equivalent
LENSAR LASER SYSTEM General $244.03
LENSAR, Inc.
Travel and Lodging
Cash or cash equivalent
LENSAR LASER SYSTEM General $221.95
LENSAR, Inc.
Travel and Lodging
Cash or cash equivalent
LENSAR LASER SYSTEM General $221.95
RxSight Inc
Food and Beverage
In-kind items and services
RXSIGHT CONTACT LENS General $221.50
Alcon Research LLC
Food and Beverage
In-kind items and services
— General $183.85
Alcon Vision LLC
Food and Beverage
In-kind items and services
— General $176.51
LENSAR, Inc.
Food and Beverage
Cash or cash equivalent
LENSAR LASER SYSTEM General $155.97
Alcon Vision LLC
Food and Beverage
In-kind items and services
— General $141.57
RxSight Inc
Entertainment
In-kind items and services
RXSIGHT CONTACT LENS General $106.00
Alcon Vision LLC
Food and Beverage
In-kind items and services
— General $102.48
RxSight Inc
Food and Beverage
In-kind items and services
RXSIGHT INJECTOR HANDPIECE General $96.29
Alcon Vision LLC
Food and Beverage
In-kind items and services
— General $95.49
Alcon Vision LLC
Food and Beverage
In-kind items and services
— General $93.79
RxSight Inc
Food and Beverage
In-kind items and services
RXSIGHT CONTACT LENS General $90.51
RxSight Inc
Food and Beverage
In-kind items and services
RXSIGHT CONTACT LENS General $80.19
RxSight Inc
Entertainment
In-kind items and services
RXSIGHT CONTACT LENS General $71.27

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
66984 Removal of cataract with insertion of prosthetic lens
231 148 $3116.88 $473.21
66821 Removal of recurring cataract in lens capsule using a laser
75 64 $900.00 $295.47
66982 Complex removal of cataract with insertion of prosthetic lens
56 35 $3553.57 $626.52
92014 Established patient complete exam of visual system
50 49 $250.00 $118.12
92136 Measurement of corneal curvature and depth of eye
40 17 $232.50 $20.18
92004 New patient complete exam of visual system
32 32 $300.00 $141.38
92012 Established patient problem focused exam of visual system
29 26 $160.00 $84.56
92134 Imaging of retina
23 22 $80.00 $36.06
76514 Ultrasound scan of cornea to determine thickness
21 20 $50.00 $10.28
92286 Imaging of front third of eye using a special microscope
17 16 $250.00 $37.30

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Prednisolone Acetate Prednisolone Acetate 468 14,263 $19,194.31 326
Ofloxacin Ofloxacin 345 4,980 $3,375.97 272
Latanoprost Latanoprost 209 11,382 $1,418.56 56
Prolensa Bromfenac Sodium 179 5,836 $61,318.51 130
Restasis Cyclosporine 125 6,525 $129,975.40 54
Xiidra Lifitegrast 122 5,400 $120,098.27 58
Moxifloxacin Moxifloxacin Hcl 106 1,265 $2,066.58 78
Bromfenac Sodium Bromfenac Sodium 104 3,074 $19,665.20 78
Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat 94 6,106 $1,103.92 43
Loteprednol Etabonate Loteprednol Etabonate 58 1,762 $6,992.78 48
Brimonidine Tartrate Brimonidine Tartrate 42 1,968 $4,916.70 14
Timolol Maleate Timolol Maleate 39 1,633 $306.54 11
Lumigan Bimatoprost 36 2,427 $20,112.52 12
Dorzolamide Hcl Dorzolamide Hcl 33 1,419 $264.65 —
Vyzulta Latanoprostene Bunod 30 1,411 $12,854.67 13
Combigan Brimonidine Tartrate/Timolol 19 845 $4,519.44 —
Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol 19 932 $2,424.42 —
Cyclosporine Cyclosporine 18 750 $6,626.96 11
Lotemax Sm Loteprednol Etabonate 17 403 $4,212.78 17
Brinzolamide Brinzolamide 17 796 $2,412.79 —
Tyrvaya Varenicline Tartrate 17 510 $11,011.99 —
Ilevro Nepafenac 14 535 $5,156.82 —
Cequa Cyclosporine 12 600 $10,832.61 —
Miebo Perfluorohexyloctane/Pf 11 330 $8,081.57 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Ophthalmology Primary Specialty

NUCC Taxonomy Code: 207W00000X

License # reported to NPPES TX F7175

An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Texas Medical Board.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - OPHTHALMOLOGY

Medicare Enrollment ID

I20120312000198

Enrollment State Jurisdiction

TX

PECOS Control ID

8921153164

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Stephen Glenn Slade Md Pa

3900 Essex Ln, Houston, TX 770275111

Phone: 7136265544

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

1 listed
NPI 1750345658

Doctor of Optometry

Career & Practice History

NPI enumerated May 10, 2006.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1386693752
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: May 10, 2006
Last Update: August 24, 2015
Sole Proprietor: No

Other Ophthalmology Specialists in Houston

All Ophthalmology Specialists in Houston

Mailing Address

3900 Essex Ln, Suite 101

Houston, TX 770275133

Phone: 7136265544

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.